Koninklijke DSM N.V.RDSMY
Price as of · delayed, not real-time
A Dutch multinational specializing in health, nutrition, and bioscience solutions, Koninklijke DSM N.V. focuses on sustainable innovation for food, dietary supplements, and materials. Investors monitor its performance due to its leadership in specialty chemicals and commitment to ESG-driven growth. The company's pivot toward biosciences and renewable materials has positioned it as a key player in sustainable industrial solutions.
Congressional Interest in Koninklijke DSM N.V. (RDSMY)
2 members of Congress have disclosed 12 trades in Koninklijke DSM N.V. (RDSMY), a Basic Materials company. The buy/sell breakdown shows 5 purchases versus 7 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Who in Congress Is Trading RDSMY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-01-24 | Daniel Goldman | sell | $1K-$15K |
| 2018-02-02 | Thomas MacArthur | sell | $1K-$15K |
| 2017-05-01 | Thomas MacArthur | sell | $1K-$15K |
| 2017-01-10 | Thomas MacArthur | buy | $1K-$15K |
| 2017-01-09 | Thomas MacArthur | buy | $1K-$15K |
| 2016-12-07 | Thomas MacArthur | sell | $1K-$15K |
| 2016-09-20 | Thomas MacArthur | buy | $1K-$15K |
| 2016-08-17 | Thomas MacArthur | sell | $1K-$15K |
| 2016-02-22 | Thomas MacArthur | buy | $15K-$50K |
| 2015-05-27 | Thomas MacArthur | sell | $50K-$100K |
| 2015-01-27 | Thomas MacArthur | sell | $1K-$15K |
| 2015-01-26 | Thomas MacArthur | buy | $15K-$50K |